Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ASND

Ascendis Pharma A/S

May 12 • 04:00PM ET

237.65

-1.02 -0.43 %

Healthcare • Biotechnology • Denmark • Large • NASD

Peers: BMRN SRPT INSM RYTM ALNY IONS KRYS UTHR FOLD VKTX

| Held by: TCAF IBB SPDW FDG AFOS QQQJ MSSM MEDI TMSL ONEQ

Scroll to Statements

Index	-	P/E	26.78	EPS (ttm)	8.87	Insider Own	0.91%	Shs Outstand	62.11M	Perf Week	5.49%
Market Cap	14.76B	Forward P/E	21.79	EPS next Y	10.90	Insider Trans	-3.33%	Shs Float	61.55M	Perf Month	-4.39%
Enterprise Value	15.13B	PEG	-	EPS next Q	1.40	Inst Own	111.71%	Short Float	4.60%	Perf Quarter	6.00%
Income	581.90M	P/S	14.68	EPS this Y	422.85%	Inst Trans	-47.30%	Short Ratio	4.00	Perf Half Y	20.18%
Sales	1.01B	P/B	26.25	EPS next Y	-23.49%	ROA	33.69%	Short Interest	2.83M	Perf YTD	11.45%
Book/sh	9.05	P/C	22.36	EPS next 5Y	-	ROE	325.80%	52W High	250.74 -5.22%	Perf Year	53.89%
Cash/sh	10.63	P/FCF	291.88	EPS past 3/5Y	27.03% 14.76%	ROIC	57.78%	52W Low	150.89 57.50%	Perf 3Y	149.11%
Dividend Est.	-	EV/EBITDA	1120.18	Sales past 3/5Y	147.23% 152.45%	Gross Margin	87.35%	Volatility	5.89% 3.93%	Perf 5Y	73.52%
Dividend TTM	-	EV/Sales	15.05	EPS Y/Y TTM	249.36%	Oper. Margin	-0.66%	ATR (14)	9.98	Perf 10Y	1484.33%
Dividend Ex-Date	-	Quick Ratio	0.72	Sales Y/Y TTM	155.14%	Profit Margin	57.88%	RSI (14)	53.60	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	787.72%	SMA20	1.77%	Beta	0.41	Target Price	292.90
Payout	-	Debt/Eq	1.84	Sales Q/Q	171.53%	SMA50	2.61%	Rel Volume	1.24	Prev Close	238.67
Employees	-	LT Debt/Eq	0.79	Earnings	May 07 BMO	SMA200	11.80%	Avg Volume	708.16K	Price	237.65
IPO	Jan 28, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	5923.61% -7.58%	Trades		Volume	875,227	Change	-0.43%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)